Securing sterility leads to union headache for Genzyme
Attempting to ensure cleanroom sterility has gotten Genzyme into hot water with Trade Unions who protested outside a Fabrazyme manufacturing plant yesterday.
Archives for October 17, 2013
GSK waiting to ramp up malaria vaccine manufacturing despite Ph III progress
GlaxSmithKline will wait to ramp up manufacturing capacity of its promising malaria vaccine until after it makes its way through the regulatory process.
Big Pharma business opportunities driving ADC boom say experts
Big Pharma interest in antibody drug conjugates (ADC) hit another high this week with Roche ,Novartis and AstraZeneca each announcing investments that boost their ability to develop and manufacture these small-molecule monoclonal antibody (mAb) drug...
Bayer extends license of 'workhorse' antibody discovery tech
Bioinvent’s n-CoDeR library has been described as a "workhorse" for antibody discovery by Bayer as it extends and broadens its license agreement.
Update
Regeneron expands NY, Ireland manufacturing sites as potential mAb shows early success
Biotech developer Regeneron is investing as much as $300m in its New York manufacturing plants and for a new site in Ireland as part of preparations for a potential new blockbuster monoclonal antibody that treats high cholesterol.